Sold by: Veradigm
Deployed on AWS
This file is a 6 month sample including the patients enrolled/active in the Diabetes Collaborative Registry in the 6 month time period of 1/1/2019 through 6/30/2019.
Overview
The Diabetes Collaborative Registry® is the first clinical ambulatory registry aimed at tracking and improving the quality of diabetes and cardiometabolic care across the primary and specialty care continuum. This interdisciplinary effort is led by Veradigm and the American College of Cardiology in partnership with the American Diabetes Association, the American College of Physicians, the American Association of Clinical Endocrinologists and the Joslin Diabetes Center. This registry is currently enrolling practices across multiple specialties, specifically primary care, family care, internal medicine, endocrinology and cardiology.
Details
New
Introducing multi-product solutions
You can now purchase comprehensive solutions tailored to use cases and industries.
Features and programs
Financing for AWS Marketplace purchases
AWS Marketplace now accepts line of credit payments through the PNC Vendor Finance program. This program is available to select AWS customers in the US, excluding NV, NC, ND, TN, & VT.
Pricing
This product is available free of charge. Free subscriptions have no end date and may be canceled any time.
Additional AWS infrastructure costs may apply. Use the AWS Pricing Calculator to estimate your infrastructure costs.
Dimensions summary
This listing uses a single pricing dimension called Product Access (Units). It is offered at no cost, so there are no paid tiers, instance sizes, or usage add-ons to compare. The dimension grants subscribers access to the product. Because only one option exists, pricing does not scale by volume, term, or feature level. You select this single unit to gain access, with nothing else to configure on the pricing side.
Top-of-mind questions for buyers
One unit grants a subscriber access to the Diabetes Collaborative Registry product. It functions as an access grant rather than a metered resource like compute or storage. Because the product is offered at no cost, adding this single unit unlocks access without any usage charges.
No. This listing carries a single free dimension with no paid tiers or usage add-ons. Cost does not scale with volume, subscriber count, or time. Access remains at no charge regardless of how you use the product. There are no thresholds or overage points to trigger a bill change.
The registry supports research on diabetes and related metabolic and cardiovascular conditions. Published analyses drawn from it examine areas such as cardiovascular risk reduction, quality of care, and treatment patterns in patients with diabetes. Access under this single unit grants entry to the product itself.
www.veradigm.com
Helpful?
Vendor refund policy
Refunds are not offered for this product.
Legal
Vendor terms and conditions
Upon subscribing to this product, you must acknowledge and agree to the terms and conditions outlined in the vendor's End User License Agreement (EULA) .
Content disclaimer
Vendors are responsible for their product descriptions and other product content. AWS does not warrant that vendors' product descriptions or other product content are accurate, complete, reliable, current, or error-free.
Delivery details
AWS Data Exchange (ADX)
AWS Data Exchange is a service that helps AWS easily share and manage data entitlements from other organizations at scale.
Additional details
You will receive access to the following data sets.
Data set name | Type | Historical revisions | Future revisions | Sensitive information | Data dictionaries | Data samples |
|---|---|---|---|---|---|---|
VERADIGM_ADX_DCR_SAMPLE | All historical revisions | No future revisions | Not included | Not included |
Resources
Vendor resources
Similar products
This model predicts the risk of receiving an initial diagnosis of diabetes over the next year.
Machine Learning model to classify the chance of Type 2 Diabetes based on laboratory measurements and medications of the subject.
Propensity model that determines the probability that a consumer has Diabetes.
Glooko is dedicated to simplifying diabetes management for healthcare providers and people living with diabetes.
World Bank Open Data provides free and open access to various global development data. This release contains diabetes prevalence (% of population ages 20 to 79) for all countries in the world. Diabetes prevalence refers to the percentage of people ages 20-79 who have type 1 or type 2 diabetes.